These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 11876755)

  • 1. Complement activation in infective endocarditis: correlation with extracardiac manifestations and prognosis.
    Messias-Reason IJ; Hayashi SY; Nisihara RM; Kirschfink M
    Clin Exp Immunol; 2002 Feb; 127(2):310-5. PubMed ID: 11876755
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Demonstration of apoptosis-associated cleavage products of DNA, complement activation products SC5b-9 and C3d/dg, and immune complexes CIC-C3d, CIC-IgA, and CIC-IgG in the urine of patients with membranous glomerulonephritis.
    Kotnik V; Premzl A; Skoberne M; Malovrh T; Kveder R; Kaplan-Pavlovcic S; Kotnik A; Stiblar-Martincic D
    Croat Med J; 2003 Dec; 44(6):707-11. PubMed ID: 14652883
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Circulating immune complexes and complement breakdown products in childhood IgA nephropathy].
    Tanaka C; Suhara Y; Kikkawa Y
    Nihon Jinzo Gakkai Shi; 1991 Aug; 33(8):709-17. PubMed ID: 1770631
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Leucocyte complement receptor 1 (CR1/CD35) transcript and its correlation with the clinical disease activity in rheumatoid arthritis patients.
    Anand D; Kumar U; Kanjilal M; Kaur S; Das N
    Clin Exp Immunol; 2014 Jun; 176(3):327-35. PubMed ID: 24433281
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Usefulness of detection of complement activation products in evaluating SLE activity.
    Nagy G; Brózik M; Varga L; Füst G; Kirschfink M; Kiss E; Gergely P
    Lupus; 2000; 9(1):19-25. PubMed ID: 10713643
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The complement fixing ability of putative circulating immune complexes in rheumatoid arthritis and its relationship to extra-articular disease.
    Bourke BE; Moss IK; Mumford P; Horsfall A; Maini RN
    Clin Exp Immunol; 1982 Jun; 48(3):726-32. PubMed ID: 6981475
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sensitivity and specificity of plasma and urine complement split products as indicators of lupus disease activity.
    Manzi S; Rairie JE; Carpenter AB; Kelly RH; Jagarlapudi SP; Sereika SM; Medsger TA; Ramsey-Goldman R
    Arthritis Rheum; 1996 Jul; 39(7):1178-88. PubMed ID: 8670328
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Elevated levels of circulating immune complexes -C3d and-C1q as a criterion for acute extraintestinal manifestations of ulcerative colitis].
    Sagynbaeva VÉ; Lazebnik LB
    Eksp Klin Gastroenterol; 2014; (7):18-24. PubMed ID: 25842401
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reflection of disease activity in rheumatoid arthritis by indices of activation of the classical complement pathway.
    Makinde VA; Senaldi G; Jawad AS; Berry H; Vergani D
    Ann Rheum Dis; 1989 Apr; 48(4):302-6. PubMed ID: 2785367
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Monoclonal antibodies against complement 3 neoantigens for detection of immune complexes and complement activation. Relationship between immune complex levels, state of C3, and numbers of receptors for C3b.
    Aguado MT; Lambris JD; Tsokos GC; Burger R; Bitter-Suermann D; Tamerius JD; Dixon FJ; Theofilopoulos AN
    J Clin Invest; 1985 Oct; 76(4):1418-26. PubMed ID: 2932466
    [TBL] [Abstract][Full Text] [Related]  

  • 11. C3 activation products, C3 containing immune complexes, the terminal complement complex and native C9 in patients with rheumatoid arthritis.
    Olmez U; Garred P; Mollnes TE; Harboe M; Berntzen HB; Munthe E
    Scand J Rheumatol; 1991; 20(3):183-9. PubMed ID: 2068540
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Complement activation products in idiopathic pulmonary fibrosis: relevance of fragment Ba to disease severity.
    Meliconi R; Senaldi G; Sturani C; Galavotti V; Facchini A; Gasbarrini G; Vergani D
    Clin Immunol Immunopathol; 1990 Oct; 57(1):64-73. PubMed ID: 2394036
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Local and systemic activation of the whole complement cascade in human leukocytoclastic cutaneous vasculitis; C3d,g and terminal complement complex as sensitive markers.
    Dauchel H; Joly P; Delpech A; Thomine E; Sauger F; Le Loet X; Lauret P; Tron F; Fontaine M; Ripoche J
    Clin Exp Immunol; 1993 May; 92(2):274-83. PubMed ID: 8485913
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Complement activation in Brazilian patients with preeclampsia.
    de Messias-Reason IJ; Aleixo V; de Freitas H; Nisihara RM; Mocelin V; Urbanetz A
    J Investig Allergol Clin Immunol; 2000; 10(4):209-14. PubMed ID: 11039837
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Correlations of C1q- and C3d-bearing circulating immune complexes with immunopathological disease activity in lupus nephritis patients.
    Muso E; Yashiro M; Ito Y; Yoshida H; Sasayama S
    Nihon Jinzo Gakkai Shi; 1994 Apr; 36(4):345-54. PubMed ID: 8022107
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Correlation of disease activity with circulating immune complexes (C1qbA) and complement breakdown products (C3D) in patients with systemic lupus erythematosus. A prospective study.
    Swaak AJ; Groenwold J; Hannema A; Hack CE
    Rheumatol Int; 1985; 5(5):215-20. PubMed ID: 3877968
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Circulating immune complexes and complement breakdown product C3d in glomerulonephritis and kidney transplantation.
    Sølling J
    Acta Pathol Microbiol Immunol Scand C; 1984 Aug; 92(4):213-20. PubMed ID: 6391086
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Complement activation in pulmonary tuberculosis.
    Sai Baba KS; Moudgil KD; Jain RC; Srivastava LM
    Tubercle; 1990 Jun; 71(2):103-7. PubMed ID: 2219459
    [TBL] [Abstract][Full Text] [Related]  

  • 19. SC5b-9 is the most sensitive marker in assessing disease activity in Brazilian SLE patients.
    Chiu YY; Nisihara RM; Würzner R; Kirschfink M; de Messias-Reason IJ
    J Investig Allergol Clin Immunol; 1998; 8(4):239-44. PubMed ID: 9777539
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fate of circulating immune complexes in infective endocarditis.
    Cabane J; Godeau P; Herreman G; Acar J; Digeon M; Bach JF
    Am J Med; 1979 Feb; 66(2):277-82. PubMed ID: 154840
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.